| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.28 | 0.09 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |